Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash from Operations (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Cash from Operations for 16 consecutive years, with 4612000.0 as the latest value for Q3 2025.

  • Quarterly Cash from Operations rose 368.45% to 4612000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 7831000.0 through Sep 2025, up 158.11% year-over-year, with the annual reading at 11896000.0 for FY2024, 25.02% down from the prior year.
  • Cash from Operations for Q3 2025 was 4612000.0 at Xtant Medical Holdings, up from 1276000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 4612000.0 in Q3 2025, with the low at 5755000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 1007736.84, with a median of 1004000.0 recorded in 2022.
  • The sharpest move saw Cash from Operations soared 955.87% in 2021, then crashed 16906.67% in 2023.
  • Over 5 years, Cash from Operations stood at 423000.0 in 2021, then plummeted by 640.9% to 2288000.0 in 2022, then surged by 60.01% to 915000.0 in 2023, then skyrocketed by 172.68% to 665000.0 in 2024, then skyrocketed by 593.53% to 4612000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 4612000.0, 1276000.0, and 1278000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.